Bullfrog AI (BFRG) and Its Competitors Financial Analysis

Bullfrog AI (NASDAQ:BFRG – Get Free Report) is one of 109 public companies in the “Life Sciences Tools & Services” industry, but how does it weigh in compared to its competitors? We will compare Bullfrog AI to related companies based on the strength of its earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Institutional & Insider Ownership

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 54.3% of shares of all “Life Sciences Tools & Services” companies are held by institutional investors. 14.7% of Bullfrog AI shares are held by insiders. Comparatively, 15.2% of shares of all “Life Sciences Tools & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Bullfrog AI and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI 1 1 0 0 1.50
Bullfrog AI Competitors 958 3198 5533 179 2.50

As a group, “Life Sciences Tools & Services” companies have a potential upside of 1.65%. Given Bullfrog AI’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Bullfrog AI has less favorable growth aspects than its competitors.

Valuation and Earnings

This table compares Bullfrog AI and its competitors gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bullfrog AI $120,000.00 -$6.50 million -0.97
Bullfrog AI Competitors $2.27 billion $55.87 billion -7.75

Bullfrog AI’s competitors have higher revenue and earnings than Bullfrog AI. Bullfrog AI is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Bullfrog AI and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bullfrog AI N/A -135.33% -118.28%
Bullfrog AI Competitors -487.52% 78.70% -13.00%

Volatility & Risk

Bullfrog AI has a beta of -2.6, indicating that its share price is 360% less volatile than the S&P 500. Comparatively, Bullfrog AI’s competitors have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.

Summary

Bullfrog AI competitors beat Bullfrog AI on 11 of the 13 factors compared.

Bullfrog AI Company Profile

(Get Free Report)

BullFrog AI Holdings, Inc. is a biotechnology technology company that applies artificial intelligence and machine learning to drug development. Its work focuses on analyzing complex biomedical data to help identify potential drug targets and understand disease-related patterns. The company’s bfLEAP platform is designed to support pharmaceutical and biotechnology research, including target validation, patient stratification and the exploration of existing drugs for new uses. BullFrog AI provides data-analysis capabilities intended to help researchers make more informed development decisions.

Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.